Tag: COVID-19

February 15, 2023
Long COVID Data in Workers’ Comp

Both the WCRI and the New York State Insurance Fund published new reports.

READ MORE
October 16, 2022
COVID-19 Workplace Lessons for Employers

The National Safety Council provides information on mental health, workplace safety, and more.

READ MORE
October 15, 2022
FDA Warns That Certain COVID-19 Variants are Not Neutralized by Evusheld

The only pre-exposure prophylactic for COVID-19 may not provide protection for certain variants.

READ MORE
September 25, 2022
FDA Authorizes Additional Round of COVID-19 Boosters

Moderna and Pfizer boosters have been updated to target the omicron variant.

READ MORE
August 25, 2022
FDA Authorizes New COVID-19 Vaccine

Novavax COVID-19 Vaccine, Adjuvanted will require two doses given three weeks apart.

READ MORE
April 19, 2022
FDA Authorizes Second COVID-19 Booster Dose for Special Populations

Adults aged 50 and older and immunocompromised individuals may receive a second booster dose.

READ MORE
February 19, 2022
FDA Fully Approves Moderna Vaccine & Expands Veklury’s Treatment Range

Drug advancements surrounding the prevention and treatment of COVID-19.

READ MORE
January 15, 2022
Additional Vaccine Candidate Performs Well in Clinical Trials

Phase 3 trials for NVX-CoV2373 across 30,000 people found this vaccine candidate to be safe and effective for the prevention of COVID-19.

READ MORE
January 14, 2022
CDC Updates Isolation and Quarantine Period for COVID-19

New five-day rules are recommended, with variation depending upon vaccination status.

READ MORE
December 20, 2021
COVID-19 Pill Approval and More Updates

Molnupiravir, Paxlovid, and AZD7442 have shown promise in Phase 3 trials.

READ MORE
1 2 3 9
lockenvelopephone-handsetmenucross-circle